UCLA Scholars Awarded 2013 Sloan Research Fellowships

University tied for second in number of new fellows selected this year

Five outstanding young professors from UCLA are among 126 scientists and scholars in the United States and Canada to receive 2013 Sloan Research Fellowships from the Alfred P. Sloan Foundation.

Two of the five UCLA recipients are members of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research Center.

Researchers Identify Cell Compartment Supporting Blood Stem Cells

UCLA researchers at the Orthopaedic Hospital Research Center and Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research (Broad Stem Cell Research Center or BSCRC) led by Bruno Péault, UCLA professor of orthopedic surgery and member of the BSCRC and of the Scottish Center for Regenerative Medicine (Edinburgh, UK), have refined a specific component of mesenchymal (bone marrow) stem cells (MSCs) called perivascular cells that support the maintenance of hematopoietic (blood) stem and progenitor cells (HSPCs), dramatically improving scientists’ capabilities for sustaining

Researchers Map Human Egg and Sperm Development

$6 Million Awarded to Physician-Scientists for Translational Grants from State Stem Cell Agency

UCLA scientists find drug that may help advance the battle against deadly Duchenne muscular dystrophy

Drugs are currently being tested that show promise in treating patients with Duchenne muscular dystrophy (DMD), an inherited disease that affects about one in 3,600 boys and results in muscle degeneration and, eventually, death.                

Modified gene therapy restores immune systems in children with “bubble boy” disease, UCLA stem cell researcher finds

UCLA stem cell researchers, led by Dr. Donald Kohn, have found that a gene therapy regimen can safely restore immune systems to children with so-called “Bubble Boy” disease, a life threatening condition that if left untreated can be fatal within one to two years.

Alternative polyadenylation factors link cell cycle to migration

A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients with Chronic Motor Deficit from Traumatic Brain Injury (TBI)

Phase II trial of AV-GBM-1 (autologous dendritic cells loaded with autologous tumor associated antigens) as an adjunctive therapy following primary surgery plus concurrent chemoradiation in patients with newly diagnosed glioblastoma

A Phase 3 Study to Compare the Efficacy and Safety of Humacytes Human Acellular Vessel with that of an Autologous Arteriovenous Fistula in Subjects with End-Stage Renal Disease

Pages